AEON Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
AEON Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2024.
  • AEON Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$8.6M, a 22.2% increase year-over-year.
  • AEON Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$35.6M, a 2281% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$8.6M +$2.46M +22.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 -$15.1M Jul 22, 2023 Sep 30, 2023 10-Q 2023-11-13
Q1 2023 -$11.1M -$10.6M -2586% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 -$412K +$143K +25.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-17
Q1 2021 -$555K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.